معرفی
Sean Tan is a Lecturer at the Victorian Heart Institute (VHI), Monash University, where he conducts clinical and translational research at the intersection of cardiology and oncology. His work is centered on understanding cardiovascular complications in cancer patients, particularly those arising from immunotherapies and targeted cancer treatments.
His research interests include:
- Cardio-Oncology and cardiotoxicity
- Cardiovascular events in cancer survivors
- Systematic reviews in stroke and coronary disease
- Clinical guidelines and preventive cardiology
Recent research outputs show a strong focus on immune checkpoint inhibitors, drug-induced cardiac complications (e.g., Dasatinib), and epidemiological patterns in cardio-oncology. His publications span high-impact journals such as International Journal of Cardiology, Heart Lung and Circulation, and European Stroke Journal, reflecting a consistent trend in clinical research, meta-analyses, and editorial commentary.
Scientific contributions include:
- Chief Investigator on the project 'The Association between Cardiovascular Disease and Cancer' (2023–2024)
- Active collaboration with leading researchers including Nerlekar N., Nicholls S.J., and Chan J.
- Significant contributions to understanding asymptomatic coronary disease and vaccine perceptions among cardiologists
Dr. Tan advises no students listed in the provided data and is involved in multi-center research with clinical and public health implications. He has no listed awards or grants beyond the named project. His work contributes to UN Sustainable Development Goal 3: Good Health and Well-being.
